Olmesartan (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Olmesartan" in English language version.

refsWebsite

Global rank English rank

12nih.gov

4^th place

7doi.org

2^nd place

3drugs.com

399^th place

333^rd place

3semanticscholar.org

11^th place

8^th place

2clincalc.com

3,912^th place

2,496^th place

1books.google.com

3^rd place

1web.archive.org

1^st place

1rxlist.com

7,927^th place

6,815^th place

1cosettepharma.com

low place

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 471. ISBN 9783527607495.

clincalc.com

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Olmesartan Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.

cosettepharma.com

"Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo". Cosette Pharma (Press release). 18 January 2022. Retrieved 14 April 2023.

doi.org

Hünseler C, Paneitz A, Friedrich D, Lindner U, Oberthuer A, Körber F, et al. (January 2011). "Angiotensin II receptor blocker induced fetopathy: 7 cases". Klinische Padiatrie. 223 (1): 10–14. doi:10.1055/s-0030-1269895. PMID 21271514. S2CID 260206339.
De Petris G, Caldero SG, Chen L, Xiao SY, Dhungel BM, Spizcka AJ, et al. (May 2014). "Histopathological changes in the gastrointestinal tract due to medications: an update for the surgical pathologist (part II of II)". International Journal of Surgical Pathology. 22 (3): 202–211. doi:10.1177/1066896913502230. PMID 24021900. S2CID 20614874.
Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, et al. (August 2012). "Severe spruelike enteropathy associated with olmesartan". Mayo Clinic Proceedings. 87 (8): 732–738. doi:10.1016/j.mayocp.2012.06.003. PMC 3538487. PMID 22728033.
Aulakh GK, Sodhi RK, Singh M (August 2007). "An update on non-peptide angiotensin receptor antagonists and related RAAS modulators". Life Sciences. 81 (8): 615–639. doi:10.1016/j.lfs.2007.06.007. PMID 17692338.
Ishizuka T, Fujimori I, Kato M, Noji-Sakikawa C, Saito M, Yoshigae Y, et al. (April 2010). "Human carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartan medoxomil in liver and intestine". The Journal of Biological Chemistry. 285 (16): 11892–11902. doi:10.1074/jbc.M109.072629. PMC 2852926. PMID 20177059.
Omboni S, Volpe M (December 2018). "Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan". Cardiovascular Therapeutics. 36 (6): e12471. doi:10.1111/1755-5922.12471. PMC 6587798. PMID 30358114.
Miyazaki M, Takai S (May 2002). "Anti-atherosclerotic efficacy of olmesartan". Journal of Human Hypertension. 16 (Suppl 2): S7-12. doi:10.1038/sj.jhh.1001393. PMID 11967727. S2CID 23755806.

drugs.com

"Olmesartan Medoxomil Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.
"Olmesartan Pregnancy and Breastfeeding Warnings". Drugs.com. Retrieved 3 March 2019.
"FDA Alert: Benicar (olmesartan): Ongoing Safety Review". Drugs.com. Retrieved 27 June 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hünseler C, Paneitz A, Friedrich D, Lindner U, Oberthuer A, Körber F, et al. (January 2011). "Angiotensin II receptor blocker induced fetopathy: 7 cases". Klinische Padiatrie. 223 (1): 10–14. doi:10.1055/s-0030-1269895. PMID 21271514. S2CID 260206339.
De Petris G, Caldero SG, Chen L, Xiao SY, Dhungel BM, Spizcka AJ, et al. (May 2014). "Histopathological changes in the gastrointestinal tract due to medications: an update for the surgical pathologist (part II of II)". International Journal of Surgical Pathology. 22 (3): 202–211. doi:10.1177/1066896913502230. PMID 24021900. S2CID 20614874.
Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, et al. (August 2012). "Severe spruelike enteropathy associated with olmesartan". Mayo Clinic Proceedings. 87 (8): 732–738. doi:10.1016/j.mayocp.2012.06.003. PMC 3538487. PMID 22728033.
Aulakh GK, Sodhi RK, Singh M (August 2007). "An update on non-peptide angiotensin receptor antagonists and related RAAS modulators". Life Sciences. 81 (8): 615–639. doi:10.1016/j.lfs.2007.06.007. PMID 17692338.
Ishizuka T, Fujimori I, Kato M, Noji-Sakikawa C, Saito M, Yoshigae Y, et al. (April 2010). "Human carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartan medoxomil in liver and intestine". The Journal of Biological Chemistry. 285 (16): 11892–11902. doi:10.1074/jbc.M109.072629. PMC 2852926. PMID 20177059.
Omboni S, Volpe M (December 2018). "Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan". Cardiovascular Therapeutics. 36 (6): e12471. doi:10.1111/1755-5922.12471. PMC 6587798. PMID 30358114.
Miyazaki M, Takai S (May 2002). "Anti-atherosclerotic efficacy of olmesartan". Journal of Human Hypertension. 16 (Suppl 2): S7-12. doi:10.1038/sj.jhh.1001393. PMID 11967727. S2CID 23755806.

ncbi.nlm.nih.gov

Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, et al. (August 2012). "Severe spruelike enteropathy associated with olmesartan". Mayo Clinic Proceedings. 87 (8): 732–738. doi:10.1016/j.mayocp.2012.06.003. PMC 3538487. PMID 22728033.
Ishizuka T, Fujimori I, Kato M, Noji-Sakikawa C, Saito M, Yoshigae Y, et al. (April 2010). "Human carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartan medoxomil in liver and intestine". The Journal of Biological Chemistry. 285 (16): 11892–11902. doi:10.1074/jbc.M109.072629. PMC 2852926. PMID 20177059.
Omboni S, Volpe M (December 2018). "Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan". Cardiovascular Therapeutics. 36 (6): e12471. doi:10.1111/1755-5922.12471. PMC 6587798. PMID 30358114.

dailymed.nlm.nih.gov

"Benicar- olmesartan medoxomil tablet, film coated". DailyMed. 7 September 2022. Retrieved 14 April 2023.
"OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE – olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet, film coated". DailyMed. U.S. National Library of Medicine.

rxlist.com

"Benicar (olmesartan medoxomil)". RxList Inc. 5 July 2007. Retrieved 22 July 2010.

semanticscholar.org

api.semanticscholar.org

Hünseler C, Paneitz A, Friedrich D, Lindner U, Oberthuer A, Körber F, et al. (January 2011). "Angiotensin II receptor blocker induced fetopathy: 7 cases". Klinische Padiatrie. 223 (1): 10–14. doi:10.1055/s-0030-1269895. PMID 21271514. S2CID 260206339.
De Petris G, Caldero SG, Chen L, Xiao SY, Dhungel BM, Spizcka AJ, et al. (May 2014). "Histopathological changes in the gastrointestinal tract due to medications: an update for the surgical pathologist (part II of II)". International Journal of Surgical Pathology. 22 (3): 202–211. doi:10.1177/1066896913502230. PMID 24021900. S2CID 20614874.
Miyazaki M, Takai S (May 2002). "Anti-atherosclerotic efficacy of olmesartan". Journal of Human Hypertension. 16 (Suppl 2): S7-12. doi:10.1038/sj.jhh.1001393. PMID 11967727. S2CID 23755806.

web.archive.org

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.